Neurothera Labs Inc.
NTLX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.06M | -1.06M | -3.86M | -- | -521.50K |
| Total Depreciation and Amortization | 42.50K | 42.50K | 50.00K | -- | 48.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 212.50K | 212.50K | 1.72M | -- | -20.50K |
| Change in Net Operating Assets | 343.00K | 343.00K | 475.00K | -- | 8.00K |
| Cash from Operations | -463.50K | -463.50K | -1.61M | -- | -486.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 60.00K | 60.00K | 710.00K | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 60.00K | 60.00K | 710.00K | -- | -- |
| Total Debt Issued | -- | -- | 1.14M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 1.39M | -- | 457.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 2.53M | -- | 457.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -403.50K | -403.50K | 1.63M | -- | -29.00K |